Why the study?
Does genetic polymorphism of CYP2C9 affect warfarin maintenance dose requirement in patients undergoing anticoagulation therapy?
Does genetic polymorphism of CYP2C9 affect warfarin maintenance dose requirement in patients undergoing anticoagulation therapy?
Answers are grounded in this paper and cite their sources.
The study investigates the relationship between CYP2C9 genetic polymorphisms and warfarin maintenance dose requirements.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Furuya et al. (1995) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: